1421760-11-3

Basic information

• Product Name: C₂₀H₃₀N₂O₈
• Synonyms: C₂₀H₃₀N₂O₈
• CAS NO: 1421760-11-3
• Molecular Weight: 426.467
• Mol File: 1421760-11-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: C₂₀H₃₀N₂O₈(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₀H₃₀N₂O₈(1421760-11-3)
• EPA Substance Registry System: C₂₀H₃₀N₂O₈(1421760-11-3)

Safety Data

• Hazardous Substances Data: 1421760-11-3(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 302-53-4 S(-)-carbidopa 

Downstream Products

• 1421760-01-1 C₃₃H₄₆N₂O₈ 

Relevant articles and documents

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS AND NEURODEGENERATIVE DISEASES

The invention relates to the compound of or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for treating or preventing neuromuscular disorders and neurodegenerative diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, or parenteral-administration, or syrup, or injection. Such compositions may be used to treatment or management of neuromuscular disorders and neurodegenerative diseases such as Parkinson's disease, scleroderma, restless leg syndrome, hypertension and gestational hypertension.

COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROMUSCULAR DISORDERS AND NEURODEGENERATIVE DISORDERS

The invention relates to the compounds of formula (I) or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula (I), and methods for treating or preventing neuromuscular disorders and neurodegenerative diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosaf intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment or management of neuromuscular disorders and neurodegenerative diseases such as Parkinson's disease, scleroderma, restless leg syndrome, hypertension and gestational hypertension.